Cases 11 - 20 of 172
CELGENE CORPORATION v. ONCOGEN PHARMA (MALAYSIA) SDN. BHD.
as 2:2022cv02952
Plaintiff:
CELGENE CORPORATION
Defendant:
ONCOGEN PHARMA (MALAYSIA) SDN. BHD.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
HEALTHCOR OFFSHORE MASTER FUND, L.P. et al v. CELGENE CORPORATION et al
as 2:2022cv02404
Plaintiff:
HEALTHCOR OFFSHORE MASTER FUND, L.P., HEALTHCOR SANATATE OFFSHORE MASTER FUND, L.P., BLACKSTONE ALTERNATIVE MULTI-STRATEGY SUB FUND IV L.L.C. and others
Defendant:
CELGENE CORPORATION, SCOTT A. SMITH, TERRIE CURRAN and others
CELGENE CORPORATION v. MSN LABORATORIES PRIVATE LIMITED et al
as 2:2022cv01993
Plaintiff:
CELGENE CORPORATION
Defendant:
MSN LABORATORIES PRIVATE LIMITED and MSN PHARMACEUTICALS INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
MSP RECOVERY CLAIMS, SERIES LLC et al v. CELGENE CORPORATION et al
as 2:2021cv20451
Plaintiff:
MSP RECOVERY CLAIMS, SERIES LLC, MSPA CLAIMS 1, LLC, MAO-MSO RECOVERY II, LLC, SERIES PMPI, A SEGREGATED SERIES OF MAO-MSO RECOVERY II, LLC and others
Defendant:
CELGENE CORPORATION and BRISTOL-MYERS SQUIBB COMPANY
Cause Of Action: 15 U.S.C. § 2
CELGENE CORPORATION v. HIKMA PHARMACEUTICALS USA, INC.
as 2:2021cv20459
Plaintiff:
CELGENE CORPORATION
Defendant:
HIKMA PHARMACEUTICALS USA, INC.
Cause Of Action: 35 U.S.C. § 271
CELGENE CORPORATION v. ALEMBIC PHARMACEUTICALS LIMITED et al
as 2:2021cv20099
Plaintiff:
CELGENE CORPORATION
Defendant:
ALEMBIC PHARMACEUTICALS LIMITED, ALEMBIC GLOBAL HOLDING SA and ALEMBIC PHARMACEUTICALS, INC.
Cause Of Action: 35 U.S.C. § 271
GIC PRIVATE LIMITED v. CELGENE CORPORATION et al
as 2:2021cv16767
Plaintiff:
GIC PRIVATE LIMITED
Defendant:
CELGENE CORPORATION, SCOTT A. SMITH, TERRIE CURRAN and others
AMERICAN CENTURY MUTUAL FUNDS, INC., on behalf of its series Select Fund, Ultra Fund, Growth Fund (solely as successor-in-interest to All Cap Growth Fund, a series of American Century Mutual Funds, In et al v. CELGENE CORPORATION et al
as 2:2021cv13785
Plaintiff:
AMERICAN CENTURY MUTUAL FUNDS, INC., on behalf of its series Select Fund, Ultra Fund, Growth Fund (solely as successor-in-interest to All Cap Growth Fund, a series of American Century Mutual Funds, In, AMERICAN CENTURY VARIABLE PORTFOLIOS, INC., on behalf of its series VP Balanced Fund, VP Disciplined Core Value Fund, VP Ultra Fund, and VP Large Company Value Fund, AMERICAN CENTURY CAPITAL PORTFOLIOS, INC., on behalf of its series Value Fund (solely as successor-in-interest to Capital Value Fund, a series of American Century Mutual Funds, Inc.), NT Focused Large and others
Defendant:
CELGENE CORPORATION, SCOTT A. SMITH, TERRIE CURRAN and others
DFA INVESTMENT DIMENSIONS GROUP INC. et al v. CELGENE CORPORATION et al
as 2:2021cv13739
Plaintiff:
DFA INVESTMENT DIMENSIONS GROUP INC., U.S. CORE EQUITY 1 PORTFOLIO, U.S. CORE EQUITY 2 PORTFOLIO and others
Defendant:
CELGENE CORPORATION, SCOTT A. SMITH, TERRIE CURRAN and others
CELGENE CORPORATION v. TORRENT PHARMACEUTICALS LTD. et al
as 2:2021cv12927
Plaintiff:
CELGENE CORPORATION
Defendant:
TORRENT PHARMA INC. and TORRENT PHARMACEUTICALS LTD.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
